Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,138,422
-
Number of holders
-
228
-
Total 13F shares, excl. options
-
127,080,415
-
Shares change
-
+2,056,772
-
Total reported value, excl. options
-
$1,781,069,063
-
Value change
-
+$21,637,125
-
Put/Call ratio
-
53%
-
Number of buys
-
122
-
Number of sells
-
110
-
Price
-
$14.02
Institutional Holders of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) as of Q2 2025
As of 30 Jun 2025 Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) had 285 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 127,080,415 shares of stock of the company.
Largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, Rubric Capital Management LP, Frazier Life Sciences Management, L.P., BlackRock, Inc., VANGUARD GROUP INC, Polar Capital Holdings Plc, STATE STREET CORP, MORGAN STANLEY, and GILDER GAGNON HOWE & CO LLC.
This table shows 285 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.